The Prevalence of Osteoporosis in Hemodialysis Patients

The purpose of this study is to determine the prevalence and severity of osteoporosis in hemodialysis patients and to evaluate potential correlations with renal bone disease indices

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteoporosis Bone Diseases Bone Diseases, Metabolic Metabolic Diseases Musculoskeletal Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Papageorgiou General Hospital

Thessaloniki, 56429, Greece

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Chronic hemodialysis
Age > 18-year old

Exclusion criteria

Prior specific osteoporosis treatment except vitamin D and calcium supplement administration; active malignancy
Recent pregnancy
Immobilization

Sponsors and collaborators

Lead sponsor

Papageorgiou General Hospital

Other

Registry information

Official study title

Prevalence of Osteoporosis in Hemodialysis Patients and Relevance With Renal Bone Disease

Important dates

Study start: 2005
Primary completion: 2007
Study completion: 2007
First posted: Mar 30, 2006
Registry last updated: Jun 6, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed